Request Sample
Request Methodology
Description
The Spirometers Market was valued at USD 605.3 million in 2020 and is projected to reach USD 717.9 million by 2027, at a CAGR of 4.8 % during 2021-2027. Spirometry is rarely used to diagnose asthma in children, especially in resource-poor nations where the burden of noncommunicable diseases is higher. Increased spirometry assessment frequency techniques can help to lower the burden of noncommunicable diseases. Unlike traditional spirometry equipment, contemporary spirometry devices standardise test data and respond quickly. The rise of ambulatory care venues has increased the demand for shorter hospital stays. Over the last few years, there has been a rise in the popularity of home healthcare. The idea of treating patients in the privacy of their own homes is one of the primary factors driving the spirometer market forward. The rise in popularity of home healthcare has prompted the creation of tele-spirometers. Also increasing demand for home healthcare is the rise in the senior population. For instance, according to WHO, between 2015 and 2050, the proportion of the world’s population over 60 years will nearly double from 12% to 22%. Moreover, grow in prevalence of various respiratory disorders such as COPD and asthma also boost the market over the forecast years. Companies are creating spirometers with enhanced design and features to make the difficult procedure of pulmonary function testing easier for patients and medical professionals. The major goal is to create spirometers that have a larger yield and provide better patient comfort without causing issues. In addition, businesses are implementing novel packing processes to prevent bacterial infections. Such technological advancements make patient testing procedures easier and more straightforward. For instance, according to World Health Organization 2016, approximately 251 Mn cases of COPD observed in 2016. In addition escalation in the R&D for the development of advanced products, fundraising from public and private sectors, rise in disposable income, and development in healthcare infrastructure in emerging countries are boost the market over the forecast timeframe. Global market is surging owing to strategic alliances and product approvals for the newer devices. For instance, In December 2016, Propeller Health collaborated with Medical International Research to integrate mobile and clinical spirometers into the Propeller platform. In September 2017, NuvoAir partnered with Novartis AG to expand the commercialization of NuvoAir’s spirometry technology to physicians worldwide
